SAP-001 is Shanton's lead investigational compound with First- and Best-in-Class potential in uncontrolled gout SINGAPORE and PRINCETON, N.J., March 28, 2025 /PRNewswire/ -- Shanton Pharma, a clinical-stage biotech company developing a novel treatment for gout, today announced topline...
Hence then, the article about shanton reveals topline data from phase 2b study in refractory gout patients was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Shanton Reveals Topline Data from Phase 2b Study in Refractory Gout Patients )
Also on site :
- GOP Lawmaker Says Trump Admin Has & 039;Overreached& 039; on Deportations
- Hairstylists Say This In-Shower Step Helps With Shedding and Scalp Issues While Encouraging Stronger, Longer Hair
- Dale Morris, Titan of Nashville Management Who Forged Superstar Careers for Kenny Chesney and Alabama, Dies at 89